ATMPsDrug DiscoveryRegulationResearchNICRodrigo Ortiz 6 October 2026 Advancing AAV Vector for Gene Therapies with URBAGEN For families affected by a rare and ultra-rare genetic disorder, the distance between a promising laboratory result and an accessible treatment can feel impossibly large. Developing a gene therapy requires much more than identifying ... More
ArticlesPacientsCell therapyResearchCTGCTNICRodrigo Ortiz 16 September 2026 From Skin Cells to Stem Cells: Reprogramming Cells to Study Disease Every cell in the human body contains essentially the same genetic instructions, yet a heart cell behaves very differently from a nerve or skin cell. For many years, scientists assumed that once a cell ... More
ArticlesPacientsGen TherapyResearchCTGCTNICRodrigo Ortiz 10 September 2026 Living Medicines: The Promise and Challenges of CAR-T Therapy Cancer treatment has undergone a remarkable transformation over the past decade. What if, instead of relying solely on drugs to attack tumors, we could reprogram a patient's own immune cells to seek out and ... More
ArticlesPacientsGen TherapyResearchCTGCTRodrigo Ortiz 27 August 2026 The Delivery Challenge of Genome Editing with CRISPR CRISPR technologies can rewrite a disease-causing DNA sequence, switch a gene off, correct a single genetic letter or even alter gene activity without changing the underlying DNA. Yet a genome editor can only work ... More
ArticlesResearchersGen TherapyResearchCTGCTNICRodrigo Ortiz 30 July 2026 Molecular Velcro: Using Coiled Coils to Deliver Genome Editors Beyond AAV Size Limits What if one of the biggest obstacles in gene therapy could be solved by borrowing a concept from everyday life? Just as Velcro joins two separate pieces together to create a strong and functional ... More
InterviewPacientsATMPsPre ClinicalResearchCTGCTNICRodrigo Ortiz 24 July 2026 Duško Lainšček interviewed by Svet24 How does a breakthrough gene therapy begin? What does it take to turn a scientific idea into a treatment that can reach a patient? In this interview, Duško Lainšček, researcher at the Institute of Chemistry ... More
EventsResearchersATMPsRegulationCTGCTRodrigo Ortiz 23 June 2026 Event Date: 9 June 2026 do: 9 June 2026 • CTGCT at GMP Symposium 2026: Contributing to ATMP Manufacturing Discussions The CTGCT was represented at the GMP Symposium 2026, held in Tuheljske Toplice, where leading experts gathered to exchange knowledge and practical experiences in GMP environments. As part of the scientific program, our head Dr. ... More
ArticlesPacientsATMPsCTGCTRodrigo Ortiz 19 June 2026 CTGCT Newsletter No. 4 Just as the summer is about to start your friend and colleague the CTGCT is publishing its latest newsletter with news and future events. Watch out! This is becoming a tradition every 6 months ... More
ArticlesResearchersGen TherapyResearchCTGCTRodrigo Ortiz 18 June 2026 Inside the GeneH Consortium Meeting and Symposium we organised On the 2nd of June 2026, the GeneH Consortium met together in Ljubljana for their yearly meeting and on the 3rd the consortium organized together with the Center for Functional Genomics and BioChips (CFGBC), ... More
EventsResearchersGen TherapyPre ClinicalResearchCTGCTNICRodrigo Ortiz 8 June 2026 Event Date: 11 May 2026 do: 15 May 2026 • CTGCT at ASGCT 2026 At the ASGCT 2026 Annual Meeting in Boston (May 11–15, 2026), held held in Boston, Massachusetts, USA, our colleague Dr. Duško Lainšček presented two pieces of work that reflect this translational reality. One of ... More
EventsPacientsCTGCTNICRodrigo Ortiz 22 May 2026 Event Date: 13 May 2026 do: 13 May 2026 • CTGCT at BioFair 5.0: connecting with the next generation of experts in gene and cell therapy On the 13th of May, part of the CTGCT team attended BioFair 5.0 the largest career event for students in the field of life sciences in Slovenia, organized by the non-profit student association BEST ... More
ArticlesPacientsATMPsPre ClinicalResearchCTGCTUCLRodrigo Ortiz 11 May 2026 Next-Generation T-Cell Therapies: From Laboratory Engineering to In Vivo Programming In our latest edition of the CTGCT Science Talks webinar series we had Dr. Thomas Fox, a clinician-scientist whose work bridges the gap between the clinical-laboratory interface working across Harvard Medical School and the ... More